Acute myeloid leukemia doxorubicin-resistant mechanism
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
To construct doxorubicin-resistant acute myeloid leukemia cell line and explore the mechanism of drug resistance
应用场景：
创建时间：
2024-07-04
相关数据集
Transcriptome-wide analysis of RNA N6-methyladenosine in Adriamycin-resistant acute myeloid leukemia cells
N6-Methyladenosine (m6A) is the most abundant post-transcriptional modification in eukaryotes, the imbalance of which is reported to be associated with various pathological processes, including drug r
NIAID Data Ecosystem60
Discovery of Novel Bifunctional Agents as Potent TRK Inhibitors and Degraders against xDFG Mutation Resistance
Despite the clinical success of tropomyosin receptor kinases (TRKs) inhibitors in NTRK fusion–positive cancers, prolonged administration has resulted in acquired resistance, particularly xDFG mutation
NIAID Data Ecosystem50
Additional file 6 of Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML
Additional file 6: Table S5. 117 scRNA Differential Expressed Genes (DEGs) in HSC-like cells between resistant and sensitive groups. These genes met with the differential expression criteria (min.pct
NIAID Data Ecosystem10
Single cell analyses reveals a non-canonical EZH2 activity as main driver of RA resistance in PLZF/RARA leukemia [scRNA-seq]
Resistance to treatment is due to the heterogeneity of the tumor which contains a subset of cancer cells that escape treatment and are responsible for the relapse. We took advantage of the PLZF/RARA r
NIAID Data Ecosystem60
Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy [RNA-Seq]
Deep sequencing has revealed that epigenetic modifiers are the most mutated genes in acute myeloid leukemia (AML). Thus, elucidating epigenetic dysregulation in AML is crucial to understand disease me
NIAID Data Ecosystem10
